Project
Illumina Body Map 2: averaged replicates
Navigation
Downloads
Results for TAF1
Z-value: 5.58
Motif logo
Transcription factors associated with TAF1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
TAF1
|
ENSG00000147133.11 | TATA-box binding protein associated factor 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| TAF1 | hg19_v2_chrX_+_70586140_70586218 | 0.12 | 5.3e-01 | Click! |
Activity profile of TAF1 motif
Sorted Z-values of TAF1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chrY_+_2803322 | 11.22 |
ENST00000383052.1
ENST00000155093.3 ENST00000449237.1 ENST00000443793.1 |
ZFY
|
zinc finger protein, Y-linked |
| chr5_-_180670880 | 8.42 |
ENST00000511566.1
ENST00000511900.1 ENST00000504726.1 ENST00000512968.1 ENST00000376817.4 ENST00000513027.1 ENST00000503081.1 ENST00000456394.2 |
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1 |
| chrY_-_15591485 | 7.42 |
ENST00000382896.4
ENST00000537580.1 ENST00000540140.1 ENST00000545955.1 ENST00000538878.1 |
UTY
|
ubiquitously transcribed tetratricopeptide repeat containing, Y-linked |
| chr14_-_23299009 | 7.13 |
ENST00000488800.1
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
| chr19_+_4791722 | 6.65 |
ENST00000269856.3
|
FEM1A
|
fem-1 homolog a (C. elegans) |
| chr12_-_46663734 | 6.58 |
ENST00000550173.1
|
SLC38A1
|
solute carrier family 38, member 1 |
| chr19_+_56111680 | 6.54 |
ENST00000301073.3
|
ZNF524
|
zinc finger protein 524 |
| chr5_-_180671172 | 6.44 |
ENST00000512805.1
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1 |
| chr11_+_118175596 | 6.43 |
ENST00000528600.1
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex) |
| chr20_+_30697510 | 6.20 |
ENST00000217315.5
|
TM9SF4
|
transmembrane 9 superfamily protein member 4 |
| chr20_+_30697298 | 6.01 |
ENST00000398022.2
|
TM9SF4
|
transmembrane 9 superfamily protein member 4 |
| chr11_+_118215036 | 5.98 |
ENST00000392883.2
ENST00000532917.1 |
CD3G
|
CD3g molecule, gamma (CD3-TCR complex) |
| chr11_-_118661588 | 5.89 |
ENST00000534980.1
ENST00000526070.2 |
DDX6
|
DEAD (Asp-Glu-Ala-Asp) box helicase 6 |
| chr14_+_23235886 | 5.84 |
ENST00000604262.1
ENST00000431881.2 ENST00000412791.1 ENST00000358043.5 |
OXA1L
|
oxidase (cytochrome c) assembly 1-like |
| chr7_+_101459263 | 5.82 |
ENST00000292538.4
ENST00000393824.3 ENST00000547394.2 ENST00000360264.3 ENST00000425244.2 |
CUX1
|
cut-like homeobox 1 |
| chr7_-_29234802 | 5.80 |
ENST00000449801.1
ENST00000409850.1 |
CPVL
|
carboxypeptidase, vitellogenic-like |
| chr11_+_118175132 | 5.76 |
ENST00000361763.4
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex) |
| chrX_-_153236620 | 5.66 |
ENST00000369984.4
|
HCFC1
|
host cell factor C1 (VP16-accessory protein) |
| chrX_+_123095155 | 5.65 |
ENST00000371160.1
ENST00000435103.1 |
STAG2
|
stromal antigen 2 |
| chr19_+_35759968 | 5.65 |
ENST00000222305.3
ENST00000595068.1 ENST00000379134.3 ENST00000594064.1 ENST00000598058.1 |
USF2
|
upstream transcription factor 2, c-fos interacting |
| chr20_-_60640866 | 5.54 |
ENST00000252996.4
|
TAF4
|
TAF4 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 135kDa |
| chr4_+_84457250 | 5.48 |
ENST00000395226.2
|
AGPAT9
|
1-acylglycerol-3-phosphate O-acyltransferase 9 |
| chr11_-_10830463 | 5.32 |
ENST00000527419.1
ENST00000530211.1 ENST00000530702.1 ENST00000524932.1 ENST00000532570.1 |
EIF4G2
|
eukaryotic translation initiation factor 4 gamma, 2 |
| chr1_+_153963227 | 5.31 |
ENST00000368567.4
ENST00000392558.4 |
RPS27
|
ribosomal protein S27 |
| chr6_+_5261225 | 5.26 |
ENST00000324331.6
|
FARS2
|
phenylalanyl-tRNA synthetase 2, mitochondrial |
| chrY_+_22737604 | 5.23 |
ENST00000361365.2
|
EIF1AY
|
eukaryotic translation initiation factor 1A, Y-linked |
| chr5_-_142784888 | 5.14 |
ENST00000514699.1
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| chrX_-_153237258 | 5.14 |
ENST00000310441.7
|
HCFC1
|
host cell factor C1 (VP16-accessory protein) |
| chr3_+_197677047 | 5.13 |
ENST00000448864.1
|
RPL35A
|
ribosomal protein L35a |
| chr16_-_30569584 | 5.11 |
ENST00000252797.2
ENST00000568114.1 |
ZNF764
AC002310.13
|
zinc finger protein 764 Uncharacterized protein |
| chr14_+_22694606 | 5.07 |
ENST00000390463.3
|
TRAV36DV7
|
T cell receptor alpha variable 36/delta variable 7 |
| chrX_-_47341928 | 5.00 |
ENST00000313116.7
|
ZNF41
|
zinc finger protein 41 |
| chr17_-_62009702 | 4.94 |
ENST00000006750.3
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta |
| chrX_-_131623043 | 4.86 |
ENST00000421707.1
|
MBNL3
|
muscleblind-like splicing regulator 3 |
| chr19_+_35759824 | 4.76 |
ENST00000343550.5
|
USF2
|
upstream transcription factor 2, c-fos interacting |
| chr19_+_10765614 | 4.76 |
ENST00000589283.1
|
ILF3
|
interleukin enhancer binding factor 3, 90kDa |
| chr19_-_40324255 | 4.76 |
ENST00000593685.1
ENST00000600611.1 |
DYRK1B
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B |
| chr20_-_49547731 | 4.75 |
ENST00000396029.3
|
ADNP
|
activity-dependent neuroprotector homeobox |
| chr17_-_58603482 | 4.53 |
ENST00000585368.1
|
APPBP2
|
amyloid beta precursor protein (cytoplasmic tail) binding protein 2 |
| chr4_+_106067943 | 4.52 |
ENST00000380013.4
ENST00000394764.1 ENST00000413648.2 |
TET2
|
tet methylcytosine dioxygenase 2 |
| chrX_-_20284958 | 4.51 |
ENST00000379565.3
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3 |
| chr3_-_12705600 | 4.49 |
ENST00000542177.1
ENST00000442415.2 ENST00000251849.4 |
RAF1
|
v-raf-1 murine leukemia viral oncogene homolog 1 |
| chrY_+_15016013 | 4.47 |
ENST00000360160.4
ENST00000454054.1 |
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked |
| chr14_+_75746781 | 4.42 |
ENST00000555347.1
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
| chr2_-_61697862 | 4.38 |
ENST00000398571.2
|
USP34
|
ubiquitin specific peptidase 34 |
| chrY_-_15591818 | 4.38 |
ENST00000382893.1
|
UTY
|
ubiquitously transcribed tetratricopeptide repeat containing, Y-linked |
| chr14_+_22508822 | 4.31 |
ENST00000390448.3
|
TRAV20
|
T cell receptor alpha variable 20 |
| chr2_+_242577097 | 4.28 |
ENST00000419606.1
ENST00000474739.2 ENST00000396411.3 ENST00000425239.1 ENST00000400771.3 ENST00000430617.2 |
ATG4B
|
autophagy related 4B, cysteine peptidase |
| chr3_-_13461807 | 4.27 |
ENST00000254508.5
|
NUP210
|
nucleoporin 210kDa |
| chr3_-_126194707 | 4.23 |
ENST00000336332.5
ENST00000389709.3 |
ZXDC
|
ZXD family zinc finger C |
| chr19_+_11546440 | 4.19 |
ENST00000589126.1
ENST00000588269.1 ENST00000587509.1 ENST00000592741.1 ENST00000593101.1 ENST00000587327.1 |
PRKCSH
|
protein kinase C substrate 80K-H |
| chr13_-_41593425 | 4.19 |
ENST00000239882.3
|
ELF1
|
E74-like factor 1 (ets domain transcription factor) |
| chr11_-_73687997 | 4.14 |
ENST00000545212.1
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
| chr2_+_149402553 | 4.13 |
ENST00000258484.6
ENST00000409654.1 |
EPC2
|
enhancer of polycomb homolog 2 (Drosophila) |
| chr3_+_197677379 | 4.09 |
ENST00000442341.1
|
RPL35A
|
ribosomal protein L35a |
| chr12_-_49075941 | 4.05 |
ENST00000553086.1
ENST00000548304.1 |
KANSL2
|
KAT8 regulatory NSL complex subunit 2 |
| chr7_+_104654623 | 4.04 |
ENST00000311117.3
ENST00000334877.4 ENST00000257745.4 ENST00000334914.7 ENST00000478990.1 ENST00000495267.1 ENST00000476671.1 |
KMT2E
|
lysine (K)-specific methyltransferase 2E |
| chr5_+_56111361 | 4.01 |
ENST00000399503.3
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
| chr16_-_74640986 | 4.00 |
ENST00000422840.2
ENST00000565260.1 ENST00000447066.2 ENST00000205061.5 |
GLG1
|
golgi glycoprotein 1 |
| chr19_+_8386371 | 4.00 |
ENST00000600659.2
|
RPS28
|
ribosomal protein S28 |
| chr16_+_68877496 | 3.99 |
ENST00000261778.1
|
TANGO6
|
transport and golgi organization 6 homolog (Drosophila) |
| chr2_+_114647617 | 3.98 |
ENST00000536059.1
|
ACTR3
|
ARP3 actin-related protein 3 homolog (yeast) |
| chr3_+_38206975 | 3.94 |
ENST00000446845.1
ENST00000311806.3 |
OXSR1
|
oxidative stress responsive 1 |
| chr5_+_176560742 | 3.93 |
ENST00000439151.2
|
NSD1
|
nuclear receptor binding SET domain protein 1 |
| chr11_-_10829851 | 3.88 |
ENST00000532082.1
|
EIF4G2
|
eukaryotic translation initiation factor 4 gamma, 2 |
| chr15_-_89010607 | 3.88 |
ENST00000312475.4
|
MRPL46
|
mitochondrial ribosomal protein L46 |
| chr5_+_176560595 | 3.86 |
ENST00000508896.1
|
NSD1
|
nuclear receptor binding SET domain protein 1 |
| chr7_+_138916231 | 3.85 |
ENST00000473989.3
ENST00000288561.8 |
UBN2
|
ubinuclein 2 |
| chr12_+_95612006 | 3.85 |
ENST00000551311.1
ENST00000546445.1 |
VEZT
|
vezatin, adherens junctions transmembrane protein |
| chrX_-_20284733 | 3.82 |
ENST00000438357.1
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3 |
| chrX_+_54556633 | 3.81 |
ENST00000336470.4
ENST00000360845.2 |
GNL3L
|
guanine nucleotide binding protein-like 3 (nucleolar)-like |
| chr4_-_151936865 | 3.80 |
ENST00000535741.1
|
LRBA
|
LPS-responsive vesicle trafficking, beach and anchor containing |
| chr4_+_6910966 | 3.80 |
ENST00000444368.1
|
TBC1D14
|
TBC1 domain family, member 14 |
| chr20_-_49547910 | 3.80 |
ENST00000396032.3
|
ADNP
|
activity-dependent neuroprotector homeobox |
| chr19_+_10765699 | 3.78 |
ENST00000590009.1
|
ILF3
|
interleukin enhancer binding factor 3, 90kDa |
| chrX_+_123094672 | 3.78 |
ENST00000354548.5
ENST00000458700.1 |
STAG2
|
stromal antigen 2 |
| chr9_+_131452239 | 3.77 |
ENST00000372688.4
ENST00000372686.5 |
SET
|
SET nuclear oncogene |
| chr19_+_507299 | 3.76 |
ENST00000359315.5
|
TPGS1
|
tubulin polyglutamylase complex subunit 1 |
| chr5_+_138629628 | 3.76 |
ENST00000508689.1
ENST00000514528.1 |
MATR3
|
matrin 3 |
| chr1_+_41157361 | 3.76 |
ENST00000427410.2
ENST00000447388.3 ENST00000425457.2 ENST00000453631.1 ENST00000456393.2 |
NFYC
|
nuclear transcription factor Y, gamma |
| chr6_+_32939964 | 3.75 |
ENST00000607833.1
|
BRD2
|
bromodomain containing 2 |
| chr1_-_231376836 | 3.75 |
ENST00000451322.1
|
C1orf131
|
chromosome 1 open reading frame 131 |
| chr16_+_30709530 | 3.73 |
ENST00000411466.2
|
SRCAP
|
Snf2-related CREBBP activator protein |
| chr14_+_22309368 | 3.72 |
ENST00000390433.1
|
TRAV12-1
|
T cell receptor alpha variable 12-1 |
| chr8_-_125740514 | 3.71 |
ENST00000325064.5
ENST00000518547.1 |
MTSS1
|
metastasis suppressor 1 |
| chr8_-_135725205 | 3.70 |
ENST00000523399.1
ENST00000377838.3 |
ZFAT
|
zinc finger and AT hook domain containing |
| chr11_-_118972575 | 3.70 |
ENST00000432443.2
|
DPAGT1
|
dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase) |
| chr17_-_47865948 | 3.70 |
ENST00000513602.1
|
FAM117A
|
family with sequence similarity 117, member A |
| chr10_+_69869237 | 3.69 |
ENST00000373675.3
|
MYPN
|
myopalladin |
| chr8_+_96146168 | 3.67 |
ENST00000519516.1
|
PLEKHF2
|
pleckstrin homology domain containing, family F (with FYVE domain) member 2 |
| chr19_-_55791058 | 3.67 |
ENST00000587959.1
ENST00000585927.1 ENST00000587922.1 ENST00000585698.1 |
HSPBP1
|
HSPA (heat shock 70kDa) binding protein, cytoplasmic cochaperone 1 |
| chr3_-_44803141 | 3.66 |
ENST00000296121.4
|
KIAA1143
|
KIAA1143 |
| chr10_-_123687943 | 3.66 |
ENST00000540606.1
ENST00000455628.1 |
ATE1
|
arginyltransferase 1 |
| chr14_+_97925151 | 3.65 |
ENST00000554862.1
ENST00000554260.1 ENST00000499910.2 |
CTD-2506J14.1
|
CTD-2506J14.1 |
| chr11_+_111957497 | 3.65 |
ENST00000375549.3
ENST00000528182.1 ENST00000528048.1 ENST00000528021.1 ENST00000526592.1 ENST00000525291.1 |
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein |
| chr4_+_129731074 | 3.64 |
ENST00000512960.1
ENST00000503785.1 ENST00000514740.1 |
PHF17
|
jade family PHD finger 1 |
| chr19_-_13044494 | 3.64 |
ENST00000593021.1
ENST00000587981.1 ENST00000423140.2 ENST00000314606.4 |
FARSA
|
phenylalanyl-tRNA synthetase, alpha subunit |
| chr4_-_151936416 | 3.63 |
ENST00000510413.1
ENST00000507224.1 |
LRBA
|
LPS-responsive vesicle trafficking, beach and anchor containing |
| chr19_-_50380536 | 3.62 |
ENST00000391832.3
ENST00000391834.2 ENST00000344175.5 |
AKT1S1
|
AKT1 substrate 1 (proline-rich) |
| chr19_+_2269485 | 3.61 |
ENST00000582888.4
ENST00000602676.2 ENST00000322297.4 ENST00000583542.4 |
OAZ1
|
ornithine decarboxylase antizyme 1 |
| chr11_+_48002076 | 3.61 |
ENST00000418331.2
ENST00000440289.2 |
PTPRJ
|
protein tyrosine phosphatase, receptor type, J |
| chr8_-_121824374 | 3.61 |
ENST00000517992.1
|
SNTB1
|
syntrophin, beta 1 (dystrophin-associated protein A1, 59kDa, basic component 1) |
| chr6_+_42531798 | 3.61 |
ENST00000372903.2
ENST00000372899.1 ENST00000372901.1 |
UBR2
|
ubiquitin protein ligase E3 component n-recognin 2 |
| chr19_+_11546093 | 3.59 |
ENST00000591462.1
|
PRKCSH
|
protein kinase C substrate 80K-H |
| chr14_+_103801140 | 3.56 |
ENST00000561325.1
ENST00000392715.2 ENST00000559130.1 ENST00000559532.1 ENST00000558506.1 |
EIF5
|
eukaryotic translation initiation factor 5 |
| chr11_-_118661828 | 3.56 |
ENST00000264018.4
|
DDX6
|
DEAD (Asp-Glu-Ala-Asp) box helicase 6 |
| chr2_+_120517174 | 3.56 |
ENST00000263708.2
|
PTPN4
|
protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte) |
| chr17_-_26684473 | 3.56 |
ENST00000540200.1
|
POLDIP2
|
polymerase (DNA-directed), delta interacting protein 2 |
| chr1_+_41157421 | 3.54 |
ENST00000372654.1
|
NFYC
|
nuclear transcription factor Y, gamma |
| chr4_+_6911502 | 3.54 |
ENST00000409757.4
|
TBC1D14
|
TBC1 domain family, member 14 |
| chr12_+_14561422 | 3.54 |
ENST00000541056.1
|
ATF7IP
|
activating transcription factor 7 interacting protein |
| chr19_+_50321528 | 3.48 |
ENST00000312865.6
ENST00000595185.1 ENST00000538643.1 |
MED25
|
mediator complex subunit 25 |
| chr3_-_183966717 | 3.48 |
ENST00000446569.1
ENST00000418734.2 ENST00000397676.3 |
ALG3
|
ALG3, alpha-1,3- mannosyltransferase |
| chr12_+_62654119 | 3.47 |
ENST00000353364.3
ENST00000549523.1 ENST00000280377.5 |
USP15
|
ubiquitin specific peptidase 15 |
| chr1_-_150849047 | 3.46 |
ENST00000354396.2
ENST00000505755.1 |
ARNT
|
aryl hydrocarbon receptor nuclear translocator |
| chr9_+_273038 | 3.44 |
ENST00000487230.1
ENST00000469391.1 |
DOCK8
|
dedicator of cytokinesis 8 |
| chr5_+_176560007 | 3.43 |
ENST00000510954.1
ENST00000354179.4 |
NSD1
|
nuclear receptor binding SET domain protein 1 |
| chr22_-_37545972 | 3.42 |
ENST00000216223.5
|
IL2RB
|
interleukin 2 receptor, beta |
| chr14_-_91976488 | 3.42 |
ENST00000554684.1
ENST00000337238.4 ENST00000428424.2 ENST00000554511.1 |
SMEK1
|
SMEK homolog 1, suppressor of mek1 (Dictyostelium) |
| chr8_-_117886563 | 3.42 |
ENST00000519837.1
ENST00000522699.1 |
RAD21
|
RAD21 homolog (S. pombe) |
| chr17_-_76719807 | 3.41 |
ENST00000589297.1
|
CYTH1
|
cytohesin 1 |
| chr16_+_30662085 | 3.40 |
ENST00000569864.1
|
PRR14
|
proline rich 14 |
| chr17_-_73258425 | 3.39 |
ENST00000578348.1
ENST00000582486.1 ENST00000582717.1 |
GGA3
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 3 |
| chr19_+_11546153 | 3.39 |
ENST00000591946.1
ENST00000252455.2 ENST00000412601.1 |
PRKCSH
|
protein kinase C substrate 80K-H |
| chr14_+_23299088 | 3.38 |
ENST00000355151.5
ENST00000397496.3 ENST00000555345.1 ENST00000432849.3 ENST00000553711.1 ENST00000556465.1 ENST00000397505.2 ENST00000557221.1 ENST00000311892.6 ENST00000556840.1 ENST00000555536.1 |
MRPL52
|
mitochondrial ribosomal protein L52 |
| chr19_+_10947251 | 3.36 |
ENST00000592854.1
|
C19orf38
|
chromosome 19 open reading frame 38 |
| chr17_-_56084578 | 3.34 |
ENST00000582730.2
ENST00000584773.1 ENST00000585096.1 ENST00000258962.4 |
SRSF1
|
serine/arginine-rich splicing factor 1 |
| chr11_+_47600562 | 3.33 |
ENST00000263774.4
ENST00000529276.1 ENST00000528192.1 ENST00000530295.1 ENST00000534208.1 ENST00000534716.2 |
NDUFS3
|
NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q reductase) |
| chr14_-_50053081 | 3.33 |
ENST00000396020.3
ENST00000245458.6 |
RPS29
|
ribosomal protein S29 |
| chr19_-_8386238 | 3.31 |
ENST00000301457.2
|
NDUFA7
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa |
| chr2_-_128568721 | 3.30 |
ENST00000322313.4
ENST00000393006.1 ENST00000409658.3 ENST00000436787.1 |
WDR33
|
WD repeat domain 33 |
| chr11_+_48002279 | 3.30 |
ENST00000534219.1
ENST00000527952.1 |
PTPRJ
|
protein tyrosine phosphatase, receptor type, J |
| chr8_+_125486939 | 3.30 |
ENST00000303545.3
|
RNF139
|
ring finger protein 139 |
| chr1_+_93544821 | 3.29 |
ENST00000370303.4
|
MTF2
|
metal response element binding transcription factor 2 |
| chr11_-_47600549 | 3.28 |
ENST00000430070.2
|
KBTBD4
|
kelch repeat and BTB (POZ) domain containing 4 |
| chrY_+_15017624 | 3.28 |
ENST00000440554.1
|
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked |
| chr1_-_55680762 | 3.27 |
ENST00000407756.1
ENST00000294383.6 |
USP24
|
ubiquitin specific peptidase 24 |
| chr19_+_48949087 | 3.27 |
ENST00000598711.1
|
GRWD1
|
glutamate-rich WD repeat containing 1 |
| chr6_+_155054459 | 3.25 |
ENST00000367178.3
ENST00000417268.1 ENST00000367186.4 |
SCAF8
|
SR-related CTD-associated factor 8 |
| chr3_+_137906109 | 3.24 |
ENST00000481646.1
ENST00000469044.1 ENST00000491704.1 ENST00000461600.1 |
ARMC8
|
armadillo repeat containing 8 |
| chr12_+_68042517 | 3.24 |
ENST00000393555.3
|
DYRK2
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 |
| chr19_+_48949030 | 3.24 |
ENST00000253237.5
|
GRWD1
|
glutamate-rich WD repeat containing 1 |
| chr4_+_56815102 | 3.23 |
ENST00000257287.4
|
CEP135
|
centrosomal protein 135kDa |
| chr12_-_57119300 | 3.23 |
ENST00000546917.1
ENST00000454682.1 |
NACA
|
nascent polypeptide-associated complex alpha subunit |
| chr16_+_30662050 | 3.23 |
ENST00000568754.1
|
PRR14
|
proline rich 14 |
| chr6_+_36164487 | 3.23 |
ENST00000357641.6
|
BRPF3
|
bromodomain and PHD finger containing, 3 |
| chr12_+_82752283 | 3.22 |
ENST00000548200.1
|
METTL25
|
methyltransferase like 25 |
| chr11_-_47600320 | 3.22 |
ENST00000525720.1
ENST00000531067.1 ENST00000533290.1 ENST00000529499.1 ENST00000529946.1 ENST00000526005.1 ENST00000395288.2 ENST00000534239.1 |
KBTBD4
|
kelch repeat and BTB (POZ) domain containing 4 |
| chr13_-_77601327 | 3.22 |
ENST00000417323.1
|
FBXL3
|
F-box and leucine-rich repeat protein 3 |
| chr17_-_4046257 | 3.22 |
ENST00000381638.2
|
ZZEF1
|
zinc finger, ZZ-type with EF-hand domain 1 |
| chr1_-_231376867 | 3.21 |
ENST00000366649.2
ENST00000318906.2 ENST00000366651.3 |
C1orf131
|
chromosome 1 open reading frame 131 |
| chr19_+_55897699 | 3.21 |
ENST00000558131.1
ENST00000558752.1 ENST00000458349.2 |
RPL28
|
ribosomal protein L28 |
| chr5_-_71616043 | 3.20 |
ENST00000508863.2
ENST00000522095.1 ENST00000513900.1 ENST00000515404.1 ENST00000457646.4 ENST00000261413.5 |
MRPS27
|
mitochondrial ribosomal protein S27 |
| chr2_+_32582086 | 3.18 |
ENST00000421745.2
|
BIRC6
|
baculoviral IAP repeat containing 6 |
| chr16_+_28985542 | 3.18 |
ENST00000567771.1
ENST00000568388.1 |
SPNS1
|
spinster homolog 1 (Drosophila) |
| chrX_-_119694538 | 3.17 |
ENST00000371322.5
|
CUL4B
|
cullin 4B |
| chr14_-_68283291 | 3.16 |
ENST00000555452.1
ENST00000347230.4 |
ZFYVE26
|
zinc finger, FYVE domain containing 26 |
| chr1_-_36851475 | 3.16 |
ENST00000373129.3
|
STK40
|
serine/threonine kinase 40 |
| chr21_+_47743995 | 3.16 |
ENST00000359568.5
|
PCNT
|
pericentrin |
| chr17_-_73257667 | 3.14 |
ENST00000538886.1
ENST00000580799.1 ENST00000351904.7 ENST00000537686.1 |
GGA3
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 3 |
| chr16_-_30569801 | 3.14 |
ENST00000395091.2
|
ZNF764
|
zinc finger protein 764 |
| chr1_-_150849174 | 3.13 |
ENST00000515192.1
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator |
| chr17_+_26684604 | 3.12 |
ENST00000292114.3
ENST00000509083.1 |
TMEM199
|
transmembrane protein 199 |
| chr6_-_42713792 | 3.12 |
ENST00000372876.1
|
TBCC
|
tubulin folding cofactor C |
| chr1_-_36851489 | 3.11 |
ENST00000373130.3
ENST00000373132.3 |
STK40
|
serine/threonine kinase 40 |
| chr12_+_82752275 | 3.11 |
ENST00000248306.3
|
METTL25
|
methyltransferase like 25 |
| chr12_-_49076002 | 3.11 |
ENST00000357861.3
ENST00000550347.1 ENST00000420613.2 ENST00000550931.1 ENST00000550870.1 |
KANSL2
|
KAT8 regulatory NSL complex subunit 2 |
| chr3_+_14989186 | 3.11 |
ENST00000435454.1
ENST00000323373.6 |
NR2C2
|
nuclear receptor subfamily 2, group C, member 2 |
| chr9_-_92112953 | 3.11 |
ENST00000339861.4
ENST00000422704.2 ENST00000455551.2 |
SEMA4D
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
| chr2_+_26467825 | 3.11 |
ENST00000545822.1
ENST00000425035.1 |
HADHB
|
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit |
| chr2_-_24583168 | 3.10 |
ENST00000361999.3
|
ITSN2
|
intersectin 2 |
| chr2_+_26467762 | 3.10 |
ENST00000317799.5
ENST00000405867.3 ENST00000537713.1 |
HADHB
|
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit |
| chr1_-_161102213 | 3.09 |
ENST00000458050.2
|
DEDD
|
death effector domain containing |
| chr16_+_30662184 | 3.09 |
ENST00000300835.4
|
PRR14
|
proline rich 14 |
| chr2_-_98612379 | 3.09 |
ENST00000425805.2
|
TMEM131
|
transmembrane protein 131 |
| chr2_-_242576864 | 3.08 |
ENST00000407315.1
|
THAP4
|
THAP domain containing 4 |
| chr7_+_7606639 | 3.07 |
ENST00000433056.1
|
MIOS
|
missing oocyte, meiosis regulator, homolog (Drosophila) |
| chr19_+_50094866 | 3.06 |
ENST00000418929.2
|
PRR12
|
proline rich 12 |
| chr4_+_129730947 | 3.05 |
ENST00000452328.2
ENST00000504089.1 |
PHF17
|
jade family PHD finger 1 |
| chr5_+_178986693 | 3.02 |
ENST00000437570.2
ENST00000393438.2 |
RUFY1
|
RUN and FYVE domain containing 1 |
| chr7_+_129251531 | 3.02 |
ENST00000393232.1
ENST00000353868.4 ENST00000539636.1 ENST00000454688.1 ENST00000223190.4 ENST00000311967.2 |
NRF1
|
nuclear respiratory factor 1 |
| chr22_+_40342819 | 3.01 |
ENST00000407075.3
|
GRAP2
|
GRB2-related adaptor protein 2 |
| chr6_+_149638876 | 3.00 |
ENST00000392282.1
|
TAB2
|
TGF-beta activated kinase 1/MAP3K7 binding protein 2 |
| chr12_+_6644443 | 2.99 |
ENST00000396858.1
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase |
| chr9_-_123342415 | 2.98 |
ENST00000349780.4
ENST00000360190.4 ENST00000360822.3 ENST00000359309.3 |
CDK5RAP2
|
CDK5 regulatory subunit associated protein 2 |
| chr11_-_47574664 | 2.97 |
ENST00000310513.5
ENST00000531165.1 |
CELF1
|
CUGBP, Elav-like family member 1 |
| chr16_+_28986085 | 2.96 |
ENST00000565975.1
ENST00000311008.11 ENST00000323081.8 ENST00000334536.8 |
SPNS1
|
spinster homolog 1 (Drosophila) |
| chr3_-_71802760 | 2.95 |
ENST00000295612.3
|
EIF4E3
|
eukaryotic translation initiation factor 4E family member 3 |
| chr15_+_40697988 | 2.94 |
ENST00000487418.2
ENST00000479013.2 |
IVD
|
isovaleryl-CoA dehydrogenase |
| chr1_+_231376941 | 2.94 |
ENST00000436239.1
ENST00000366647.4 ENST00000366646.3 ENST00000416000.1 |
GNPAT
|
glyceronephosphate O-acyltransferase |
| chr1_+_1167594 | 2.94 |
ENST00000379198.2
|
B3GALT6
|
UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6 |
| chr2_+_242577027 | 2.92 |
ENST00000402096.1
ENST00000404914.3 |
ATG4B
|
autophagy related 4B, cysteine peptidase |
| chr2_+_114647504 | 2.92 |
ENST00000263238.2
|
ACTR3
|
ARP3 actin-related protein 3 homolog (yeast) |
| chr4_+_6911171 | 2.91 |
ENST00000448507.1
|
TBC1D14
|
TBC1 domain family, member 14 |
| chr19_-_3985455 | 2.90 |
ENST00000309311.6
|
EEF2
|
eukaryotic translation elongation factor 2 |
| chr1_+_16693578 | 2.89 |
ENST00000401088.4
ENST00000471507.1 ENST00000401089.3 ENST00000375590.3 ENST00000492354.1 |
SZRD1
|
SUZ RNA binding domain containing 1 |
| chr5_+_109025067 | 2.87 |
ENST00000261483.4
|
MAN2A1
|
mannosidase, alpha, class 2A, member 1 |
| chr19_-_16582754 | 2.86 |
ENST00000602151.1
ENST00000597937.1 ENST00000535753.2 |
EPS15L1
|
epidermal growth factor receptor pathway substrate 15-like 1 |
| chr11_-_116968987 | 2.85 |
ENST00000434315.2
ENST00000292055.4 ENST00000375288.1 ENST00000542607.1 ENST00000445177.1 ENST00000375300.1 ENST00000446921.2 |
SIK3
|
SIK family kinase 3 |
| chr6_+_111279763 | 2.84 |
ENST00000329970.7
|
GTF3C6
|
general transcription factor IIIC, polypeptide 6, alpha 35kDa |
Network of associatons between targets according to the STRING database.
First level regulatory network of TAF1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.8 | 13.9 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 2.8 | 11.0 | GO:0019046 | release from viral latency(GO:0019046) |
| 2.6 | 10.3 | GO:0016598 | protein arginylation(GO:0016598) |
| 2.4 | 9.5 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 2.1 | 17.0 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 1.7 | 8.6 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 1.7 | 10.2 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 1.6 | 16.4 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 1.6 | 11.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 1.6 | 4.7 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 1.5 | 6.2 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 1.4 | 8.6 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
| 1.4 | 2.8 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 1.4 | 8.4 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 1.4 | 2.7 | GO:0006429 | leucyl-tRNA aminoacylation(GO:0006429) |
| 1.4 | 5.4 | GO:0090299 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 1.3 | 9.4 | GO:0051697 | protein delipidation(GO:0051697) |
| 1.3 | 15.6 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 1.3 | 5.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 1.3 | 6.4 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 1.2 | 3.7 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 1.2 | 6.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 1.2 | 4.9 | GO:1904800 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 1.2 | 8.5 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 1.2 | 3.6 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 1.2 | 2.3 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
| 1.1 | 3.4 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 1.1 | 3.4 | GO:0061485 | memory T cell proliferation(GO:0061485) |
| 1.1 | 5.6 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 1.1 | 2.2 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 1.1 | 1.1 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 1.1 | 1.1 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 1.1 | 4.3 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 1.1 | 3.2 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 1.1 | 4.2 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 1.0 | 5.2 | GO:1902904 | negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 1.0 | 4.1 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 1.0 | 4.0 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 1.0 | 6.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 1.0 | 3.0 | GO:0044209 | AMP salvage(GO:0044209) |
| 1.0 | 3.0 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 1.0 | 4.0 | GO:0060922 | cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
| 1.0 | 6.9 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 1.0 | 5.9 | GO:0070541 | response to platinum ion(GO:0070541) |
| 1.0 | 13.6 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 1.0 | 6.7 | GO:0035624 | receptor transactivation(GO:0035624) |
| 1.0 | 3.8 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.9 | 0.9 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.9 | 3.8 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
| 0.9 | 2.8 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.9 | 2.8 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
| 0.9 | 2.8 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.9 | 4.6 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.9 | 2.7 | GO:1902824 | positive regulation of late endosome to lysosome transport(GO:1902824) |
| 0.9 | 3.6 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.9 | 5.4 | GO:0015887 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.9 | 3.6 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.9 | 0.9 | GO:0031929 | TOR signaling(GO:0031929) regulation of TOR signaling(GO:0032006) |
| 0.9 | 6.2 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
| 0.9 | 6.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.9 | 3.5 | GO:2001176 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.9 | 1.7 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.8 | 2.5 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) RNA repair(GO:0042245) |
| 0.8 | 12.3 | GO:0070071 | proton-transporting V-type ATPase complex assembly(GO:0070070) proton-transporting two-sector ATPase complex assembly(GO:0070071) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.8 | 6.5 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 0.8 | 10.6 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.8 | 2.4 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
| 0.8 | 4.0 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.8 | 4.7 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
| 0.8 | 4.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.7 | 4.5 | GO:0061724 | lipophagy(GO:0061724) |
| 0.7 | 11.2 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.7 | 6.0 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.7 | 2.2 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
| 0.7 | 5.2 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.7 | 3.7 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.7 | 2.2 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.7 | 1.4 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.7 | 4.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.7 | 7.1 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.7 | 7.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.7 | 9.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.7 | 9.0 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
| 0.7 | 2.7 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.7 | 4.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
| 0.7 | 4.7 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.7 | 8.7 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.7 | 6.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.7 | 5.3 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.7 | 5.3 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.7 | 7.9 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.7 | 3.9 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 0.6 | 4.5 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
| 0.6 | 1.9 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
| 0.6 | 6.4 | GO:0033183 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 0.6 | 16.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.6 | 7.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.6 | 9.0 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.6 | 1.9 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.6 | 7.6 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.6 | 1.9 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
| 0.6 | 2.5 | GO:0015966 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.6 | 1.9 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.6 | 5.0 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
| 0.6 | 5.5 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.6 | 4.3 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.6 | 4.8 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 0.6 | 1.8 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.6 | 2.4 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
| 0.6 | 1.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.6 | 1.2 | GO:0000967 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.6 | 7.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.6 | 2.9 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.6 | 5.9 | GO:0040031 | snRNA modification(GO:0040031) |
| 0.6 | 4.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.6 | 7.0 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.6 | 0.6 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
| 0.6 | 2.9 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.6 | 0.6 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
| 0.6 | 5.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.6 | 6.8 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.6 | 3.4 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.6 | 4.5 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.6 | 1.7 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
| 0.6 | 19.4 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.5 | 3.3 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.5 | 1.6 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
| 0.5 | 1.1 | GO:0043201 | response to leucine(GO:0043201) |
| 0.5 | 6.5 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
| 0.5 | 1.6 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.5 | 3.7 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.5 | 3.7 | GO:0060356 | leucine import(GO:0060356) |
| 0.5 | 1.6 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.5 | 3.1 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.5 | 1.6 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.5 | 1.5 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
| 0.5 | 5.7 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.5 | 3.1 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 0.5 | 5.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.5 | 1.5 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.5 | 2.5 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.5 | 4.0 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.5 | 1.5 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 0.5 | 5.5 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.5 | 9.5 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.5 | 7.0 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.5 | 11.4 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.5 | 5.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.5 | 4.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.5 | 2.0 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.5 | 2.9 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.5 | 1.9 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.5 | 3.9 | GO:1901297 | positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
| 0.5 | 19.0 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.5 | 1.0 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
| 0.5 | 2.9 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.5 | 1.9 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 0.5 | 4.3 | GO:0030242 | pexophagy(GO:0030242) |
| 0.5 | 1.9 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.5 | 0.9 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
| 0.5 | 5.1 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.5 | 0.9 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.5 | 1.4 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.5 | 7.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.5 | 1.4 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.5 | 1.8 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.5 | 1.8 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.5 | 2.3 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
| 0.4 | 1.3 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.4 | 2.2 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.4 | 1.7 | GO:0051029 | rRNA transport(GO:0051029) |
| 0.4 | 3.5 | GO:0060701 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
| 0.4 | 6.9 | GO:0060242 | contact inhibition(GO:0060242) |
| 0.4 | 8.6 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.4 | 3.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.4 | 1.7 | GO:0032208 | regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
| 0.4 | 1.3 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
| 0.4 | 10.7 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.4 | 1.7 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.4 | 1.7 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.4 | 2.1 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.4 | 4.2 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.4 | 3.8 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.4 | 1.7 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.4 | 47.0 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.4 | 3.7 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.4 | 1.2 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.4 | 0.8 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.4 | 4.1 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
| 0.4 | 3.7 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.4 | 8.8 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.4 | 1.6 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.4 | 2.0 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.4 | 5.1 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.4 | 2.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.4 | 1.5 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.4 | 11.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.4 | 3.0 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.4 | 1.1 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.4 | 1.1 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.4 | 2.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.4 | 1.8 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.4 | 1.5 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 0.4 | 3.3 | GO:0043622 | cortical microtubule organization(GO:0043622) establishment of centrosome localization(GO:0051660) |
| 0.4 | 5.1 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.4 | 2.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
| 0.4 | 1.5 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.4 | 3.2 | GO:0000023 | maltose metabolic process(GO:0000023) |
| 0.4 | 6.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.4 | 2.1 | GO:0009397 | folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.4 | 1.8 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.4 | 2.8 | GO:0061198 | fungiform papilla formation(GO:0061198) |
| 0.4 | 1.4 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.3 | 6.3 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.3 | 49.2 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.3 | 2.8 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.3 | 1.0 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 0.3 | 2.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) histone H2A phosphorylation(GO:1990164) |
| 0.3 | 7.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.3 | 24.8 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.3 | 3.4 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.3 | 1.7 | GO:0007538 | primary sex determination(GO:0007538) |
| 0.3 | 4.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.3 | 1.0 | GO:0018315 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.3 | 1.7 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.3 | 1.0 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
| 0.3 | 11.8 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.3 | 0.7 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.3 | 1.0 | GO:0007388 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.3 | 10.7 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.3 | 11.3 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.3 | 2.6 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.3 | 1.6 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
| 0.3 | 3.8 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.3 | 0.6 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.3 | 1.3 | GO:0070895 | transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
| 0.3 | 3.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.3 | 0.3 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
| 0.3 | 2.8 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.3 | 3.7 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
| 0.3 | 0.6 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
| 0.3 | 0.9 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.3 | 5.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.3 | 5.7 | GO:1903012 | positive regulation of bone development(GO:1903012) |
| 0.3 | 2.4 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.3 | 1.2 | GO:0072334 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.3 | 2.1 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.3 | 0.6 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
| 0.3 | 2.4 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.3 | 7.3 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.3 | 2.0 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.3 | 2.6 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.3 | 8.7 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
| 0.3 | 3.8 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.3 | 5.4 | GO:0045738 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
| 0.3 | 1.7 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.3 | 2.8 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
| 0.3 | 0.9 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.3 | 3.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.3 | 0.9 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
| 0.3 | 3.4 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.3 | 0.8 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.3 | 3.0 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
| 0.3 | 1.4 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.3 | 1.4 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.3 | 2.2 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
| 0.3 | 1.1 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 0.3 | 2.7 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.3 | 3.0 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.3 | 2.2 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.3 | 2.2 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.3 | 0.3 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
| 0.3 | 3.9 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.3 | 0.8 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.3 | 13.5 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.3 | 0.5 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
| 0.3 | 2.8 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
| 0.3 | 0.3 | GO:0070417 | cellular response to cold(GO:0070417) |
| 0.3 | 3.8 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.3 | 8.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.3 | 1.0 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.3 | 4.0 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.2 | 1.7 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.2 | 0.7 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.2 | 2.0 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.2 | 9.6 | GO:0006379 | mRNA cleavage(GO:0006379) |
| 0.2 | 1.0 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.2 | 3.4 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.2 | 3.8 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.2 | 4.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.2 | 0.9 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.2 | 4.2 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.2 | 1.7 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.2 | 2.8 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.2 | 2.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.2 | 3.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.2 | 3.5 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.2 | 0.9 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 0.2 | 2.6 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
| 0.2 | 1.2 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.2 | 4.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.2 | 13.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.2 | 1.4 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.2 | 1.1 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.2 | 1.1 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.2 | 6.9 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.2 | 1.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.2 | 2.0 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.2 | 1.5 | GO:1904550 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 0.2 | 2.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.2 | 5.0 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.2 | 7.4 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.2 | 0.9 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
| 0.2 | 1.3 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 0.2 | 2.3 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.2 | 2.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.2 | 4.4 | GO:0016246 | RNA interference(GO:0016246) |
| 0.2 | 0.8 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.2 | 13.1 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.2 | 2.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.2 | 1.2 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.2 | 1.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.2 | 1.8 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.2 | 3.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.2 | 0.8 | GO:0036292 | DNA rewinding(GO:0036292) |
| 0.2 | 2.6 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.2 | 1.8 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.2 | 4.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.2 | 3.3 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.2 | 1.4 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.2 | 1.9 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.2 | 2.3 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
| 0.2 | 6.3 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) |
| 0.2 | 1.9 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.2 | 1.3 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.2 | 1.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.2 | 0.6 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.2 | 2.8 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.2 | 2.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.2 | 2.0 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.2 | 0.5 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.2 | 2.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.2 | 1.3 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 0.2 | 6.3 | GO:0003016 | respiratory system process(GO:0003016) |
| 0.2 | 2.0 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.2 | 0.4 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.2 | 2.0 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.2 | 1.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.2 | 2.5 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
| 0.2 | 3.7 | GO:0007379 | segment specification(GO:0007379) |
| 0.2 | 4.5 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.2 | 2.4 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.2 | 4.5 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
| 0.2 | 4.3 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.2 | 5.8 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.2 | 2.9 | GO:2000637 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.2 | 4.4 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.2 | 1.0 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.2 | 1.7 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.2 | 1.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
| 0.2 | 18.9 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.2 | 5.0 | GO:0042255 | ribosome assembly(GO:0042255) |
| 0.2 | 2.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.2 | 20.6 | GO:0006413 | translational initiation(GO:0006413) |
| 0.2 | 1.3 | GO:1902065 | response to L-glutamate(GO:1902065) |
| 0.2 | 2.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.2 | 7.8 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
| 0.2 | 0.8 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.2 | 2.1 | GO:1904869 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
| 0.2 | 1.9 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.2 | 11.0 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.2 | 0.5 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
| 0.2 | 8.4 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.2 | 1.9 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.2 | 1.4 | GO:0046189 | melanin metabolic process(GO:0006582) phenol-containing compound metabolic process(GO:0018958) secondary metabolic process(GO:0019748) melanin biosynthetic process(GO:0042438) secondary metabolite biosynthetic process(GO:0044550) phenol-containing compound biosynthetic process(GO:0046189) |
| 0.2 | 1.8 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.2 | 0.8 | GO:0072708 | response to sorbitol(GO:0072708) |
| 0.2 | 4.9 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.2 | 3.6 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.2 | 0.8 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.1 | 0.9 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
| 0.1 | 4.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.1 | 1.0 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.1 | 1.3 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.1 | 0.7 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.1 | 4.6 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 | 2.8 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 | 1.5 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.1 | 2.5 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
| 0.1 | 0.7 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
| 0.1 | 4.6 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
| 0.1 | 0.4 | GO:1903660 | negative regulation of complement-dependent cytotoxicity(GO:1903660) |
| 0.1 | 3.7 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.1 | 1.0 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
| 0.1 | 0.4 | GO:0019233 | sensory perception of pain(GO:0019233) |
| 0.1 | 1.8 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.1 | 4.0 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 | 5.9 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.1 | 4.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 | 10.5 | GO:0016073 | snRNA metabolic process(GO:0016073) |
| 0.1 | 0.7 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin biosynthetic process(GO:0032049) |
| 0.1 | 0.9 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.1 | 1.4 | GO:0052205 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.1 | 1.5 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
| 0.1 | 8.5 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.1 | 1.5 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.1 | 2.1 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.1 | 0.4 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.1 | 6.7 | GO:2000142 | regulation of DNA-templated transcription, initiation(GO:2000142) |
| 0.1 | 0.7 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.1 | 2.7 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 | 1.4 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 | 3.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.1 | 3.8 | GO:0016569 | covalent chromatin modification(GO:0016569) |
| 0.1 | 2.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 | 15.7 | GO:0016573 | histone acetylation(GO:0016573) |
| 0.1 | 2.3 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
| 0.1 | 2.6 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.1 | 2.6 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
| 0.1 | 0.7 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.1 | 6.1 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
| 0.1 | 2.1 | GO:0090316 | positive regulation of intracellular protein transport(GO:0090316) |
| 0.1 | 0.6 | GO:0045007 | depurination(GO:0045007) |
| 0.1 | 0.5 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.1 | 2.7 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
| 0.1 | 1.0 | GO:0061157 | mRNA destabilization(GO:0061157) |
| 0.1 | 1.9 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
| 0.1 | 1.2 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
| 0.1 | 1.1 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.1 | 2.6 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.1 | 3.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 0.1 | 0.7 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 | 1.4 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
| 0.1 | 0.7 | GO:0045047 | protein targeting to ER(GO:0045047) |
| 0.1 | 1.4 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.1 | 1.1 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.1 | 5.5 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
| 0.1 | 0.6 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 0.1 | 2.4 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
| 0.1 | 4.0 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
| 0.1 | 2.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 | 0.5 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.1 | 0.7 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar Purkinje cell layer maturation(GO:0021691) cerebellar cortex maturation(GO:0021699) |
| 0.1 | 2.5 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.1 | 0.5 | GO:0071348 | response to interleukin-11(GO:0071105) cellular response to interleukin-11(GO:0071348) |
| 0.1 | 1.2 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
| 0.1 | 1.3 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.1 | 3.7 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.1 | 1.6 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
| 0.1 | 6.4 | GO:0015804 | neutral amino acid transport(GO:0015804) |
| 0.1 | 5.7 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
| 0.1 | 0.7 | GO:0019043 | establishment of viral latency(GO:0019043) establishment of integrated proviral latency(GO:0075713) |
| 0.1 | 1.4 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) glycosylceramide biosynthetic process(GO:0046476) |
| 0.1 | 0.3 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 0.1 | 0.8 | GO:0032099 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.1 | 1.4 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
| 0.1 | 6.0 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
| 0.1 | 1.7 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.1 | 2.1 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
| 0.1 | 0.8 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) DNA methylation involved in embryo development(GO:0043045) negative regulation of actin nucleation(GO:0051126) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.1 | 0.6 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
| 0.1 | 0.6 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.1 | 0.8 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 | 1.8 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.1 | 0.4 | GO:0006817 | phosphate ion transport(GO:0006817) |
| 0.1 | 5.5 | GO:0006414 | translational elongation(GO:0006414) |
| 0.1 | 2.1 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 | 0.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 | 2.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 | 3.2 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
| 0.1 | 0.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 | 0.1 | GO:1902075 | cellular response to salt(GO:1902075) response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
| 0.1 | 1.2 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.1 | 2.5 | GO:0045661 | regulation of myoblast differentiation(GO:0045661) |
| 0.1 | 1.9 | GO:1903432 | regulation of TORC1 signaling(GO:1903432) |
| 0.1 | 0.8 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 | 1.1 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
| 0.1 | 1.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 | 0.5 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.1 | 1.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
| 0.1 | 8.9 | GO:0008033 | tRNA processing(GO:0008033) |
| 0.1 | 3.7 | GO:1990090 | cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.1 | 1.4 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.1 | 4.8 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
| 0.1 | 0.2 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.1 | 4.4 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
| 0.1 | 1.4 | GO:0016574 | histone ubiquitination(GO:0016574) |
| 0.1 | 2.0 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
| 0.1 | 1.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.1 | 6.4 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.1 | 4.5 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
| 0.1 | 2.0 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.1 | 2.2 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.1 | 2.4 | GO:0010165 | response to X-ray(GO:0010165) |
| 0.1 | 2.0 | GO:1903313 | positive regulation of mRNA metabolic process(GO:1903313) |
| 0.1 | 2.1 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 | 2.7 | GO:0045332 | phospholipid translocation(GO:0045332) |
| 0.1 | 2.9 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.1 | 1.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
| 0.1 | 1.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 | 0.3 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
| 0.1 | 2.0 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.1 | 5.3 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.1 | 1.5 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 | 6.3 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 |